BR0111692A - Processo para preparação de polipeptìdeo il-18 fisiologicamente ativo - Google Patents

Processo para preparação de polipeptìdeo il-18 fisiologicamente ativo

Info

Publication number
BR0111692A
BR0111692A BR0111692-4A BR0111692A BR0111692A BR 0111692 A BR0111692 A BR 0111692A BR 0111692 A BR0111692 A BR 0111692A BR 0111692 A BR0111692 A BR 0111692A
Authority
BR
Brazil
Prior art keywords
polypeptide
physiologically active
preparing physiologically
preparing
activating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
BR0111692-4A
Other languages
English (en)
Inventor
Kyung O Johanson
Roberth B Kirkpatrick
Alan R Shatzman
Yen Sen Ho
Patrik Mcdevitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GLAXOSMITHKLINE LLC (US)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR0111692A publication Critical patent/BR0111692A/pt
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE POLIPEPTìDEO IL-18 FISIOLOGICAMENTE ATIVO". Um processo para produção de um polipeptídeo fisiologicamente ativo, compreendendo contato de um polipeptídeo precursor com uma enzima de ativação, ou co-expressão de polipeptídeo com uma protease de ativação.
BR0111692-4A 2000-06-15 2001-06-11 Processo para preparação de polipeptìdeo il-18 fisiologicamente ativo Withdrawn BR0111692A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21183200P 2000-06-15 2000-06-15
US22412800P 2000-08-10 2000-08-10
US26492301P 2001-01-20 2001-01-20
PCT/US2001/018804 WO2001098455A2 (en) 2000-06-15 2001-06-11 Method for preparing a physiologically active il-18 polypeptide

Publications (1)

Publication Number Publication Date
BR0111692A true BR0111692A (pt) 2005-08-30

Family

ID=27395664

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111692-4A Withdrawn BR0111692A (pt) 2000-06-15 2001-06-11 Processo para preparação de polipeptìdeo il-18 fisiologicamente ativo

Country Status (25)

Country Link
US (2) US7186528B2 (pt)
EP (1) EP1292697B1 (pt)
JP (1) JP5121109B2 (pt)
KR (1) KR20030022144A (pt)
CN (1) CN100390281C (pt)
AR (1) AR033979A1 (pt)
AT (1) ATE437234T1 (pt)
AU (2) AU8044201A (pt)
BR (1) BR0111692A (pt)
CA (1) CA2412730C (pt)
CZ (1) CZ20024085A3 (pt)
DE (1) DE60139316D1 (pt)
DK (1) DK1292697T3 (pt)
ES (1) ES2329875T3 (pt)
HK (1) HK1055138A1 (pt)
HU (1) HUP0501002A3 (pt)
IL (2) IL153422A0 (pt)
MX (1) MXPA02012292A (pt)
MY (1) MY136526A (pt)
NO (1) NO330682B1 (pt)
NZ (1) NZ522845A (pt)
PL (2) PL208592B1 (pt)
PT (1) PT1292697E (pt)
SI (1) SI1292697T1 (pt)
WO (1) WO2001098455A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2399148A1 (en) * 2000-02-10 2001-08-16 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
DE602004025799D1 (de) 2003-04-15 2010-04-15 Glaxosmithkline Llc Humane il-18 substitutionsmutanten und deren konjugate
JP2007529195A (ja) * 2003-08-15 2007-10-25 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インク． 歯周病の診断，治療，およびモニタリングのためのＰｏｒｐｈｙｒｏｍｏｎａｓｇｉｎｇｉｖａｌｉｓ毒性ポリヌクレオチドの同定
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
MXPA06005837A (es) * 2003-11-24 2007-01-26 Novo Nordisk As Proteinas de fusion y metodos de desdoblamiento de tales proteinas.
WO2006023623A2 (en) * 2004-08-20 2006-03-02 Smithkline Beecham Corporation Methods of healing wounds by administering human il-18
EP2059253A4 (en) 2006-09-14 2011-09-14 Univ Pennsylvania MODULATION OF REGULATORY T CELLS BY HUMAN IL-18
PE20090190A1 (es) * 2007-03-23 2009-03-22 Smithkline Beecham Corp Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
EP3178484B1 (en) 2014-08-07 2019-07-24 Hyogo College Of Medicine Therapeutic agent for cancer which comprises combination of il-18 and molecule-targeting antibody
JP2019023165A (ja) * 2015-12-11 2019-02-14 国立大学法人京都大学 インターロイキン−１８活性阻害剤
KR20200080749A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 N-말단의 메티오닌이 절단된 목적 단백질 발현용 유전자 발현 카세트 및 이를 이용하여 n-말단의 메티오닌이 절단된 목적 단백질을 생산하는 방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5985863A (en) * 1996-09-12 1999-11-16 Vertex Pharmaceuticals, Inc. Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
US5192324A (en) 1982-02-18 1993-03-09 Howmedica Inc. Bone prosthesis with porous coating
EP0324789B1 (en) * 1986-10-02 2003-08-20 Massachusetts Institute Of Technology Methods of regulating metabolic stability of proteins
JP3041644B2 (ja) 1990-05-09 2000-05-15 マサチューセッツ インスティチュート オブ テクノロジー ユビキチン特異的プロテアーゼ
US5212058A (en) 1990-05-09 1993-05-18 Massachusetts Institute Of Technology Nucleic acid encoding ubiquitin-specific proteases
US5914254A (en) 1993-08-02 1999-06-22 Celtrix Pharmaceuticals, Inc. Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
US6110701A (en) 1994-04-08 2000-08-29 Merck Frosst Canada & Co. DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II)
US5552536A (en) 1994-04-08 1996-09-03 Merck Frosst Canada, Inc. DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III)
DE69519454T2 (de) 1994-07-14 2001-05-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
TW464656B (en) 1994-11-15 2001-11-21 Hayashibara Biochem Lab Interferon-gamma production inducing polypeptide monoclonal antibody, and agent for interferon-gamma susceptive disease
JP2724987B2 (ja) 1994-11-15 1998-03-09 株式会社林原生物化学研究所 インターフェロン−γの産生を誘導するポリペプチド
US6074050A (en) 1997-12-03 2000-06-13 Hewlett-Packard Company Method and apparatus for venting an ink container
AU1341797A (en) 1995-12-29 1997-07-28 Incyte Pharmaceuticals, Inc. Nucleic acids encoding interferon gamma inducing factor-2
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
TW515843B (en) * 1996-07-25 2003-01-01 Hayashibara Biochem Lab Process for producing an active polypeptide inducing interferon-γ production
JP4010606B2 (ja) * 1996-07-25 2007-11-21 株式会社林原生物化学研究所 ポリペプチドの製造方法
US6054487A (en) 1997-03-18 2000-04-25 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
EP1049790A1 (en) * 1998-01-23 2000-11-08 Novo Nordisk A/S Process for making desired polypeptides in yeast

Also Published As

Publication number Publication date
DK1292697T3 (da) 2009-11-16
MY136526A (en) 2008-10-31
HUP0501002A2 (en) 2006-01-30
PL208592B1 (pl) 2011-05-31
HUP0501002A3 (en) 2010-01-28
CA2412730C (en) 2011-08-16
AR033979A1 (es) 2004-01-21
CN100390281C (zh) 2008-05-28
ATE437234T1 (de) 2009-08-15
AU8044201A (en) 2002-01-02
PT1292697E (pt) 2009-10-28
AU2001280442B2 (en) 2005-10-27
CA2412730A1 (en) 2001-12-27
IL153422A (en) 2011-03-31
US7186528B2 (en) 2007-03-06
EP1292697B1 (en) 2009-07-22
EP1292697A2 (en) 2003-03-19
JP2004523204A (ja) 2004-08-05
CN1436246A (zh) 2003-08-13
NO20026002L (no) 2003-02-12
NO20026002D0 (no) 2002-12-13
ES2329875T3 (es) 2009-12-02
SI1292697T1 (sl) 2009-12-31
US20060177422A1 (en) 2006-08-10
CZ20024085A3 (cs) 2003-05-14
US7442526B2 (en) 2008-10-28
MXPA02012292A (es) 2003-04-25
JP5121109B2 (ja) 2013-01-16
HK1055138A1 (en) 2003-12-24
DE60139316D1 (de) 2009-09-03
IL153422A0 (en) 2003-07-06
WO2001098455A3 (en) 2002-08-08
NZ522845A (en) 2005-07-29
NO330682B1 (no) 2011-06-06
WO2001098455A2 (en) 2001-12-27
KR20030022144A (ko) 2003-03-15
EP1292697A4 (en) 2005-08-10
PL366134A1 (en) 2005-01-24
US20030143198A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
DE60139944D1 (de) Niederviskose konzentrierte proteinformulierungen
BR0114475A (pt) Célula para a produção de composição de anticorpo
MXPA02004666A (es) Gelatinas recombinantes.
BR9908890A (pt) Processo de fabricação de uma agulha através da deposição conformacional em um molde de duas peças, agulha, e, molde de duas peças para uso na construção conformacional de uma agulha
BR0215405A (pt) Composições e processos de uso de collajolie
DE60044515D1 (de) Azithromycinmonohydrat
AR025428A1 (es) Formas de administracion de tramadol retardadas mediante un revestimiento que contiene la sustancia activa tramadol en forma de sacarinato de tramadol asicomo eventualmente otros excipientes
ATE332366T1 (de) Dipeptidyl-peptidasen
BR0111692A (pt) Processo para preparação de polipeptìdeo il-18 fisiologicamente ativo
AU2002221908A1 (en) Novel use of protein hydrolysates
AU1441397A (en) Moulded spherical ceramic body, a manufacturing process for this, and the use thereof
AU2001237353A1 (en) Ultraphobic surface structure having a plurality of hydrophilic areas
ITTO20010321A0 (it) Procedimento per la trasmissione di messaggi sms con identita' protetta.
DE60222759D1 (de) Proteinsyntheseverfahren mit zellfreiem proteinsynthesesystem
CA97633S (en) Trimmer
USD478411S1 (en) Pair of shoe soles with sizing indicators
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
DE50204475D1 (de) Präparationen von vitamin e in kombination mit afamin
BR0010499A (pt) Agentes endoparasiticidas
IT1306132B1 (it) Anodo perfezionato, procedimento per la sua fabbricazione eprocedimento per la produzione di alluminio.
IT1302261B1 (it) Processo per la risoluzione cinetica enzimatica di 3-fenilglicidatiper transesterificazione con amminoalcoli
IT1286761B1 (it) Procedimento di produzione di stoppini per contenitori di soluzioni vaporizzabili, in particolare soluzioni insetticide.
NO984365D0 (no) IgAl proteasefragment som bµrerpeptid
IT1303276B1 (it) Procedimento di idrolisi del lattosio per contatto di questo con unmateriale solido di supporto enzimatico, impianto per la realizzazione

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: GLAXOSMITHKLINE LLC (US)

Free format text: NOME ALTERADO DE: SMITHKLINE BEECHAM CORPORATION

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2232 DE 15/10/2013.